Deciphering FAK in intrahepatic cholangiocarcinoma: A novel therapeutic target?
- PMID: 34252516
- DOI: 10.1016/j.jhep.2021.06.048
Deciphering FAK in intrahepatic cholangiocarcinoma: A novel therapeutic target?
Conflict of interest statement
Conflict of interest The authors declare no conflicts of interest that pertain to this work. Please refer to the accompanying ICMJE disclosure forms for further details.
Comment on
-
Focal adhesion kinase (FAK) promotes cholangiocarcinoma development and progression via YAP activation.J Hepatol. 2021 Oct;75(4):888-899. doi: 10.1016/j.jhep.2021.05.018. Epub 2021 May 28. J Hepatol. 2021. PMID: 34052254 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous